findmyKOL

Lydia Gedmintas, MD

Basic profile

Brigham and Women's Hospital

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Lydia Gedmintas is a Rheumatology/Immunology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 19 publications with 1,270 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
19publications

Distinct works indexed by OpenAlex.

1,270citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    34.3%
    Folate Analog Metabolic Inhibitor14.4%
    Methotrexate100%
    Part D34 patients
    TNF inhibitor10.7%
    Enbrel Sureclick44%Humira(Cf) Pen41%Humira Pen15%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    22.3%
    Corticosteroid21%
    Prednisone100%
    Part D46 patients
    Antidiarrheal microorganisms1.3%
    Folic Acid100%
    Part D<11 patients
  • Nervous system

    17.1%
    Nonsteroidal Anti-inflammatory Drug7.3%
    Meloxicam81%Ibuprofen19%
    Part D<11 patients
    Gabapentinoids4.3%
    Gabapentin68%Pregabalin32%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)37% facility · 63% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”